Veracyte, Inc. (VCYT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 01:04PM EDT. Market open.
| Previous Close | 28.57 |
| Open | 28.62 |
| Bid | 29.24 x 100 |
| Ask | 29.31 x 100 |
| Day's Range | 28.62 - 29.44 |
| 52 Week Range | 18.61 - 33.33 |
| Volume | |
| Avg. Volume | 953,535 |
| Market Cap | 2.248B |
| Beta (5Y Monthly) | 1.66 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.74 |
| Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34.57 |
ZacksHere's Why VCYT Stock Could be a Great Addition to Your Portfolio Now
Veracyte looks poised to deliver robust performance owing to its progress with key drivers and the strength in its diagnostics tests.
GuruFocus.comInsider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)
Chief Commercial Officer-CLIA John Leite executed a sale of 5,479 shares of Veracyte Inc (NASDAQ:VCYT) on September 4, 2024, as reported in a recent SEC Filing. Following this transaction, the insider now owns 76,174 shares of the company. The shares were sold at a price of $29.78, valuing the transaction at approximately $163,194.62.
ZacksVeracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.